The government will no longer provide free universal Covid-19 testing for most of the public from 1 April, as part of its plan for living with the virus. While people can currently still order lateral ...

A recent study published on the medRxiv* preprint server discusses the role of lateral flow device (LFD) testing in potentially improving coronavirus disease 2019 (COVID-19) isolation policies. Study: ...

Last month, Prime Minister Boris Johnson announced that free Covid-19 testing for most groups will end under England’s plans to live with coronavirus. He said the country would now deal with the virus ...

Coronavirus tests have become increasingly easier to get hold of as the pandemic has progressed. Now more than 163 million Covid-19 tests have been taken in the UK since the start of the pandemic, ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

After over two years, we're finally seeing a return to somewhat of a 'normal' life in a post-pandemic world, with the government recently announcing its plans for how we'll be "living with COVID-19".

Record numbers of people in England and Wales are testing positive for covid-19. Here’s what you need to know about how lateral flow tests work, why symptoms may linger even if a person is no longer ...

Routine asymptomatic testing across health and social care settings has come to an end this month and the official Covid survey has been axed. The final Office for National Statistics (ONS) infection ...

Free Covid tests will now be available only to vulnerable groups and some NHS staff, as the government ends free testing for the majority of the population. From 1 April, most people in England will ...

The proportion of COVID-19 infections missed by the Innova lateral flow test (LFT) are “substantial enough to be of clinical importance” according to an analysis published in The BMJ. The study by ...